My Cart
You have no items in your shopping cart.
12 items
Creating an account has many benefits:
# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3734216 | Functional | Increase in insulin release in mouse BetaTC6 cells assessed as relative insulin release activity at 10 uM incubated for 2 to 4 hrs by FRET based HTRF assay relative to sunitinib | Mus musculus | 355 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
2. | ALA3734218 | ADME | Cytotoxic activity against mouse C2C12 cells assessed as inhibition of cell proliferation of at 2 to 10 uM incubated for 72 hrs by MTT assay | Mus musculus | 9 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
3. | ALA3734221 | Binding | Inhibition of Scyl1 in mouse BetaTC6 cells assessed as increase in insulin release at 2 to 10 uM incubated for 2 hrs in presence of high glucose media by ELISA | Mus musculus | 5 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
4. | ALA3734222 | ADME | Effect on insulin release in mouse BetaTC6 cells assessed as ratio of insulin release incubated for 2 hrs in presence of low glucose media by ELISA relative to DMSO | Mus musculus | 7 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
5. | ALA3734258 | ADME | Cytotoxic activity against mouse BetaTC6 cells assessed as inhibition of cell proliferation at 10 uM incubated for 72 hrs by MTT assay | Mus musculus | 3 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
6. | ALA3734262 | Binding | Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 2 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit) | Mus musculus | 5 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
7. | ALA3734263 | Binding | Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 5 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit) | Mus musculus | 5 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
8. | ALA3734264 | Binding | Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 10 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit) | Mus musculus | 5 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
9. | ALA3734265 | Binding | Inhibition of Scyl1 in mouse C2C12 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO | Mus musculus | 7 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
10. | ALA3734266 | Binding | Inhibition of Scyl1 in mouse BetaTC6 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO | Mus musculus | 7 | ALA3727361 | cell-based format | Patent Bioactivity Data | |
11. | ALA4483863 | Functional | Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent inhibition of light emission compared to control. (Single Point Inhibition, %) | Plasmodium berghei | 9,989 | ALA4483862 | organism-based format | Winzeler Lab Plasmodium Screening Data | |
12. | ALA4483864 | Functional | Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent inhibition of light emission compared to control. (Single Point Inhibition, %) | Homo sapiens | 9,989 | ALA4483862 | cell-based format | Winzeler Lab Plasmodium Screening Data |